Titan Pharmaceuticals Inc (TTNP) — Strategic Asset Allocation Index
Titan Pharmaceuticals Inc (TTNP) has a Strategic Asset Allocation Index of 13.5% as of September 2022. Strategic assets (PP&E of $481.00K plus long-term investments of $-) total $481.00K, measured against net assets of $3.55 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Titan Pharmaceuticals Inc balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Titan Pharmaceuticals Inc Strategic Asset Allocation Index (2000–2021)
This chart shows how Titan Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 18 annual periods from 2000 to 2021. As of September 2022, the index stands at 13.5%, representing strategic assets of $481.00K against net assets of $3.55 Million USD. For live market cap and overall valuation, see market cap of Titan Pharmaceuticals Inc.
Annual Strategic Asset Allocation Index for Titan Pharmaceuticals Inc (2000–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Titan Pharmaceuticals Inc from 2000 to 2021, covering 18 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Titan Pharmaceuticals Inc net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 14.0% | $717.00K | $717.00K | $- | $5.14 Million | ▼ -7.5 pp |
| 2020 | 21.5% | $759.00K | $759.00K | $- | $3.53 Million | ▼ -63.2 pp |
| 2019 | 84.7% | $1.21 Million | $1.21 Million | $- | $1.43 Million | ▲ +73.1 pp |
| 2018 | 11.6% | $794.00K | $794.00K | $- | $6.83 Million | ▼ -57.8 pp |
| 2017 | 69.4% | $595.00K | $595.00K | $- | $857.00K | ▲ +63.1 pp |
| 2016 | 6.3% | $837.00K | $837.00K | $- | $13.19 Million | ▼ -8.6 pp |
| 2015 | 14.9% | $1.04 Million | $1.04 Million | $- | $6.99 Million | ▲ +0.2 pp |
| 2014 | 14.7% | $1.27 Million | $1.27 Million | $- | $8.61 Million | ▼ -13.1 pp |
| 2013 | 27.8% | $1.60 Million | $1.60 Million | $- | $5.76 Million | ▲ +12.6 pp |
| 2008 | 15.3% | $275.00K | $275.00K | $- | $1.80 Million | ▲ +13.8 pp |
| 2007 | 1.5% | $388.00K | $388.00K | $- | $26.59 Million | ▼ -2.5 pp |
| 2006 | 3.9% | $457.00K | $457.00K | $- | $11.65 Million | ▼ -0.8 pp |
| 2005 | 4.7% | $788.00K | $788.00K | $- | $16.60 Million | ▲ +1.8 pp |
| 2004 | 3.0% | $1.04 Million | $1.04 Million | $- | $34.95 Million | ▲ +1.3 pp |
| 2003 | 1.7% | $789.00K | $789.00K | $- | $45.67 Million | ▲ +0.4 pp |
| 2002 | 1.4% | $979.00K | $979.00K | $- | $71.98 Million | ▲ +0.8 pp |
| 2001 | 0.6% | $575.00K | $575.00K | $- | $101.37 Million | ▲ +0.1 pp |
| 2000 | 0.5% | $593.00K | $593.00K | $- | $115.98 Million | — |